HMF Replenish

Highest potency probiotic capsule for short-term intensive therapy

Probiotic with 100 billion CFU*/serving
Highest potency probiotic capsule available on the market.

Convenient capsule format
Increases patient compliance.

14-day dosage
Ideal for short-term colonization and support of gastrointestinal flora repopulation during and post antibiotic use.

Prebiotic included
Prebiotic (FOS) stimulates growth of beneficial bacteria in the digestive system.

Serving Size: 1 capsule
Servings Per Container: 14

Active Ingredients:

• Probiotic Consortium. 100 billion CFU
  • Lactobacillus acidophilus (CUL-60)
  • Lactobacillus acidophilus (CUL- 21)
  • Bifidobacterium bifidum (CUL-20)
  • Bifidobacterium animalis subsp. lactis (CUL-34)
  • Lactobacillus salivarius (CUL-61)
• Fructooligosaccharides (FOS). 100 mg

Inactive Ingredients: Hypromellose, silica, magnesium stearate

Recommended Dosage:
Adults and Children (4 years and older): Take one capsule daily with a meal, or as recommended by your healthcare practitioner.

Risk information: If you are experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain; or if you have an immune-compromised condition, do not use. If symptoms of digestive upset occur, worsen or persist beyond three days, discontinue use and consult your healthcare practitioner.

This product does not contain: wheat, gluten, dairy, soy, corn, fish, shellfish, peanuts, tree nuts, eggs, artificial colors, flavors or preservatives.  

Seroyal research-driven probiotic therapies:

• Clinically proven in randomized, double-blind, placebo-controlled adult human trials at 25 billion CFU to:
  • Reduce symptoms of Irritable Bowel Syndrome (IBS)3
  • Prevent intestinal microflora disruption post antibiotics4, 5
  • Reduce the incidence of C. difficile associated diarrhoea (Pilot study)6
• Proprietary non-pathogenic human-sourced microflora bacterial strains
  • Strong epithelial adherence
  • Naturally high tolerance to stomach acid

References:

1. Roberfroid M. Prebiotics: The Concept Revisited. J Nutr 2007 Mar;137(3 Suppl 2):830S-7S.
2. Sabater-Molina M, et al. Dietary fructooligosaccharides and potential benefits on health. J Physiol Biochem. 2009 Sep;65(3):315-28.
3. Williams EA, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. 2009; 29(1): 97-103.
4. Plummer SF, et al. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents. 2005; 26(1); 69-74.
5. Madden JA, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol. 2005; (6): 1091-7.
6. Plummer S, et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004;7(1):59-62.